Literature DB >> 20584751

Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium.

Michael W Carew1, Elaine M Leslie.   

Abstract

Simultaneous exposure of lab animals to toxic doses of the human carcinogen arsenic (As) and the essential trace element selenium (Se) results in a remarkable mutual detoxification. A likely basis for this is the in vivo formation and biliary excretion of seleno-bis(S-glutathionyl) arsinium ion [(GS)(2)AsSe](-); however, the transport protein responsible for the biliary efflux of [(GS)(2)AsSe](-) has not been identified. The multidrug resistance protein 2 (MRP2/ABCC2) is an adenosine triphosphate (ATP)-binding cassette transporter expressed at the canalicular membrane of hepatocytes. Rat Mrp2 is known to excrete the As glutathione (GSH/GS-) conjugates arsenic triglutathione [As(GS)(3)] and monomethyl arsenic diglutathione [CH(3)As(GS)(2)] into bile, and in vitro studies have established As(GS)(3) as a substrate for human MRP2. In the present study, membrane vesicles prepared from human embryonic kidney (HEK293T) cells transfected with human MRP2 were used to demonstrate that MRP2 transports [(GS)(2)AsSe](-). In addition, the characteristics of MRP2 transport of As(GS)(3) and [(GS)(2)AsSe](-) were investigated. As(GS)(3) and [(GS)(2)AsSe](-) are chemically labile and have the potential to dissociate. However, arsenite (As(III)) +/- selenite (Se(IV)) transport was not detected in the absence of GSH or in the presence of the non-reducing GSH analog, ophthalmic acid, suggesting that the conjugates are the transported forms. The apparent K(m) values for [(GS)(2)AsSe](-) and As(GS)(3) were 1.7 and 4.2 microM, respectively, signifying high relative affinities. Membrane vesicles prepared from human erythrocytes, which express the MRP2-related MRP1/ABCC1, MRP4/ABCC4 and MRP5/ABCC5, transported As(GS)(3) in an MRP1- and ATP-dependent manner but did not transport [(GS)(2)AsSe](-). These results have important implications for the Se-dependent and -independent disposition of As.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584751     DOI: 10.1093/carcin/bgq125

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Elemental and chemically specific X-ray fluorescence imaging of biological systems.

Authors:  M Jake Pushie; Ingrid J Pickering; Malgorzata Korbas; Mark J Hackett; Graham N George
Journal:  Chem Rev       Date:  2014-08-07       Impact factor: 60.622

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Functional Profiling Identifies Determinants of Arsenic Trioxide Cellular Toxicity.

Authors:  Amin Sobh; Alex Loguinov; Gulce Naz Yazici; Rola S Zeidan; Abderrahmane Tagmount; Nima S Hejazi; Alan E Hubbard; Luoping Zhang; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

4.  Altered arsenic disposition in experimental nonalcoholic fatty liver disease.

Authors:  Mark J Canet; Rhiannon N Hardwick; April D Lake; Michael J Kopplin; George L Scheffer; Walter T Klimecki; A Jay Gandolfi; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2012-06-14       Impact factor: 3.922

5.  Arsenic retention in erythrocytes and excessive erythrophagocytosis is related to low selenium status by impaired redox homeostasis.

Authors:  Zhihui Cai; Yutian Zhang; Weijie Zhang; Jinmin Ye; Qinjie Ling; Zhi Xing; Sichun Zhang; Peter R Hoffmann; Youbin Liu; Weidong Yang; Zhi Huang
Journal:  Redox Biol       Date:  2022-04-25       Impact factor: 10.787

6.  SLCO1B1 variants and urine arsenic metabolites in the Strong Heart Family Study.

Authors:  Matthew O Gribble; Venkata Saroja Voruganti; Cheryl D Cropp; Kevin A Francesconi; Walter Goessler; Jason G Umans; Ellen K Silbergeld; Sandra L Laston; Karin Haack; Wen Hong Linda Kao; Margaret Daniele Fallin; Jean W Maccluer; Shelley A Cole; Ana Navas-Acien
Journal:  Toxicol Sci       Date:  2013-08-22       Impact factor: 4.849

Review 7.  Arsenic and antimony transporters in eukaryotes.

Authors:  Ewa Maciaszczyk-Dziubinska; Donata Wawrzycka; Robert Wysocki
Journal:  Int J Mol Sci       Date:  2012-03-15       Impact factor: 6.208

8.  Arsenic Metabolism in Children Differs From That in Adults.

Authors:  Helena Skröder Löveborn; Maria Kippler; Ying Lu; Sultan Ahmed; Doris Kuehnelt; Rubhana Raqib; Marie Vahter
Journal:  Toxicol Sci       Date:  2016-04-07       Impact factor: 4.849

Review 9.  Chronic Kidney Disease and Exposure to Nephrotoxic Metals.

Authors:  Sarah E Orr; Christy C Bridges
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

10.  Multidrug resistance-associated protein 4 is a determinant of arsenite resistance.

Authors:  Bo Yuan; Yuta Yoshino; Hisayo Fukushima; Svetlana Markova; Norio Takagi; Hiroo Toyoda; Deanna L Kroetz
Journal:  Oncol Rep       Date:  2015-10-22       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.